Company Filing History:
Years Active: 2013-2017
Title: Kumi Morimoto: Innovator in Transdermal Drug Delivery
Introduction
Kumi Morimoto is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal drug delivery systems. With a total of 3 patents to her name, Morimoto's work has the potential to enhance the effectiveness of medicinal treatments.
Latest Patents
One of her latest patents is a transdermal preparation that comprises a multivalent metal chloride, a basic drug having an amino group, and an ester group-containing base material. This innovative formulation is useful due to its excellent drug content stability. Another notable patent is for a medicated patch that contains a medicinal agent, an adhesive base material, and a tackifier. The medicinal agent in this patch is varenicline or a pharmaceutically acceptable salt thereof. The adhesive base material is a rubbery adhesive, and the tackifier can be either rosin-based or non-rosin-based, with specific solubilizers included to enhance the medicinal agent's effectiveness.
Career Highlights
Kumi Morimoto is currently employed at Hisamitsu Pharmaceutical Company, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving patient outcomes through innovative drug delivery methods.
Collaborations
Throughout her career, Morimoto has collaborated with notable colleagues, including Akio Takeuchi and Kenji Ishigaki. These partnerships have contributed to her success and the advancement of her projects.
Conclusion
Kumi Morimoto's contributions to the field of pharmaceuticals, particularly in transdermal drug delivery, highlight her innovative spirit and dedication to improving healthcare solutions. Her patents reflect a commitment to enhancing the stability and effectiveness of medicinal treatments.